Table 3.

Name, developmental phase, and pharmacological data of the five purchased compounds selected for antiviral activity experiments on the SARS-CoV-2 helicase.

Name	Developmental Phase	Pharmacological Data
Ceftaroline fosamil	Approved	Antibacterial activity [28]
NADH	Approved Nutraceutical	Nutritional and vitamin supplementation [29]
PF-03715455	Investigational	In clinical trials for the treatment of asthma, pulmonary disease, chronic obstructive, and Chronic Obstructive Pulmonary Disease (COPD) ClinicalTrials.gov (NCT02219048)
PF-00610355	Investigational	In clinical trials for the treatment of lung disease, pulmonary disease, asthma, and bronchial diseases ClinicalTrials.gov (NCT00783406)
Polydatin	Approved	Anti-inflammatory, immunoregulatory, anti-oxidative, and anti-tumor activities [30]